{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:11:39Z","timestamp":1788858699634,"version":"build-2803163510"},"reference-count":33,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Oncol.","Current Oncology"],"abstract":"<jats:p>Background: The emergence of oral anticancer medications (OAMs) has increased demand for specialized clinical pharmacy services (CPSs). Concurrently, Canadian cross-sectional data highlights undergraduate education gaps, with fewer than 14% of community pharmacists reporting adequate training on OAM therapies. We designed, implemented, and evaluated a pharmacist-led Oral Anticancer Medication Clinical Co-op Program (OAMCCP) to bridge this experiential education gap while cost-effectively expanding institutional capacity. Methods: Launched in Fall 2022, the OAMCCP integrated one PharmD student per 16-week term into a multidisciplinary oncology specialty pharmacy. Trainees executed core ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs), including Best Possible Medication Histories (BPMHs), drug\u2013drug interaction (DDI) screenings, and proactive adherence and toxicity follow-up. Student competency was verified by a licensed oncology pharmacist to maintain patient safety. Impact was quantified via self-reported task logging over 15 weeks, standardized 10-point patient satisfaction surveys, payroll expenditure comparisons, and student testimonials. Results: Trainees completed 673 clinical tasks (~45 tasks\/week), contributing 16.2 h of direct clinical support weekly\u2014effectively adding +0.43 full-time equivalent (FTE) to service capacity. Mean patient satisfaction was 9.5\/10 (n = 29), with students successfully managing inquiries in 96.5% of encounters. Financially, a 1.0 FTE student (44,700 CAD\/year cost) captured clinical capacity valued at 69,300 CAD\/year (0.43 FTE pharmacist equivalence). Conclusions: The OAMCCP resolves experiential training gaps while presenting a safe, scalable, and financially viable human resource framework that expands oncology pharmacy services.<\/jats:p>","DOI":"10.3390\/curroncol33090523","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:19:26Z","timestamp":1788232766000},"page":"523","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation and Resource Optimization of an Oral Anticancer Medication Clinical Pharmacy Trainee Program: Operational and Financial Impact at a Tertiary Cancer Centre"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-4248","authenticated-orcid":false,"given":"Christine","family":"Peragine","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Flay","family":"Charbonneau","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Susan","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7109-4620","authenticated-orcid":false,"given":"Carlo","family":"DeAngelis","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada"},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Moreira, A., Bernardo, C., Ramos, C., Aguiar, P., and Alves da Costa, F. (2022). National Trends in the Use of Oral Chemotherapy over 13 Years. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.909948"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41573-023-00723-4","article-title":"Trends in the Approval of Cancer Therapies by the FDA in the Twenty-First Century","volume":"22","author":"Scott","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Paolella, G., Boyd, A., Wirth, S., Cuellar, S., Venepalli, N., and Crawford, S. (2018). Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations. Pharmacy, 6.","DOI":"10.3390\/pharmacy6010023"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1200\/JOP.18.00581","article-title":"2018 Hematology\/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard","volume":"15","author":"Mackler","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1188\/18.ONF.597-606","article-title":"Impact of Oral Anticancer Medication from a Family Caregiver Perspective","volume":"45","author":"Marshall","year":"2018","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_6","first-page":"831","article-title":"Predictors of Adherence to Oral Anticancer Medications: An Analysis of 2010\u20132018 US Nationwide Claims","volume":"28","author":"Vyas","year":"2022","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.3390\/curroncol30120744","article-title":"Patient Adherence to Oral Anticancer Agents: A Mapping Review of Supportive Interventions","volume":"30","author":"Ahmed","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1634\/theoncologist.2015-0405","article-title":"A Systematic Review of Adherence to Oral Antineoplastic Therapies","volume":"21","author":"Greer","year":"2016","journal-title":"Oncologist"},{"key":"ref_9","first-page":"259","article-title":"Clinical Pharmacy Services in Ambulatory Oncology: An Environmental Scan of the Canadian Practice Landscape","volume":"75","author":"Tibensky","year":"2022","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_10","first-page":"1029","article-title":"Multi-Disciplinary Proactive Follow-up Algorithm for Patients with Advanced NSCLC Receiving Afatinib","volume":"27","author":"Cheema","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1200\/OP-25-00353","article-title":"Development of Ambulatory Oncology Clinical Pharmacy Key Performance Indicators Using a Modified Delphi Consensus Approach","volume":"22","author":"McFarlane","year":"2025","journal-title":"JCO Oncol. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1200\/JCO.20.03088","article-title":"The Randomized AMBORA Trial: Impact of Pharmacological\/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment with New Oral Anticancer Agents","volume":"39","author":"Durr","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1078155213504975","article-title":"Are Community Pharmacists Equipped to Ensure the Safe Use of Oral Anticancer Therapy in the Community Setting? Results of a Cross-Country Survey of Community Pharmacists in Canada","volume":"20","author":"Abbott","year":"2014","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1177\/1078155220907650","article-title":"Managing Chemotherapy-Related Toxicities in the Community Setting: A Survey of Pharmacists in Ontario","volume":"26","author":"Vu","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/08858190902973143","article-title":"Oncology Education in Canadian Undergraduate and Postgraduate Training Programs","volume":"24","author":"Cheung","year":"2009","journal-title":"J. Cancer Educ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5688\/ajpe78471","article-title":"Cost Savings Associated with Pharmacy Student Interventions During APPEs","volume":"78","author":"Shepler","year":"2014","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5688\/ajpe778164","article-title":"V Potential Cost Avoidance of Pharmacy Students\u2019 Patient Care Activities During Advanced Pharmacy Practice Experiences","volume":"77","author":"Woolley","year":"2013","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s40670-019-00723-3","article-title":"Cost Savings and Clinical Interventions Made by PharmD Students During APPE Rotations at Federally Qualified Health Centers","volume":"29","author":"Tualla","year":"2019","journal-title":"Med. Sci. Educ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4212\/cjhp.v72i3.2904","article-title":"Advanced Strategies in Pharmacy Experiential Education","volume":"72","author":"Legal","year":"2019","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.2146\/ajhp170181","article-title":"Efficient and Effective Precepting of Pharmacy Students in Acute and Ambulatory Care Rotations: A Delphi Expert Panel Study","volume":"74","author":"Ignoffo","year":"2017","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1345\/aph.1Q544","article-title":"Value of the Student Pharmacist to Experiential Practice Sites: A Review of the Literature","volume":"46","author":"Mersfelder","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/1060028015577445","article-title":"Development of Clinical Pharmacy Key Performance Indicators for Hospital Pharmacists Using a Modified Delphi Approach","volume":"49","author":"Fernandes","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"ref_23","unstructured":"(2026, August 23). Health Standards Organization the Best Oral Chemotherapy Safety (BOCS) Program\u2014An Interprofessional Pursuit of Excellence. Available online: https:\/\/healthstandards.org\/leading-practice\/the-best-oral-chemotherapy-safety-bocs-program-an-interprofessional-pursuit-of-excellence\/."},{"key":"ref_24","first-page":"143","article-title":"The Sunnybrook Odette Cancer Centre Oral Anticancer Medication (OAM) Program","volume":"76","author":"Peragine","year":"2023","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4212\/cjhp.v69i2.1543","article-title":"Measurement of Clinical Pharmacy Key Performance Indicators to Focus and Improve Your Hospital Pharmacy Practice","volume":"69","author":"Lo","year":"2016","journal-title":"Can. J. Hosp. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11096-024-01717-x","article-title":"Clinical Pharmacy Key Performance Indicators for Hospital Inpatient Setting: A Systematic Review","volume":"46","author":"Magedanz","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5688\/ajpe75590","article-title":"Implementation of a School-Wide Clinical Intervention Documentation System","volume":"75","author":"Stevenson","year":"2011","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.2146\/ajhp150593","article-title":"Expanding Care through a Layered Learning Practice Model","volume":"73","author":"Bates","year":"2016","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102114","DOI":"10.1016\/j.cptl.2024.102114","article-title":"Pharmacists in Oncology: Evidence Still Needed, but Teaching Comes First","volume":"16","year":"2024","journal-title":"Curr. Pharm. Teach. Learn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102583","DOI":"10.1016\/j.cptl.2026.102583","article-title":"Implementing an Oncology Elective in a Doctor of Pharmacy Curriculum","volume":"18","author":"Barash","year":"2026","journal-title":"Curr. Pharm. Teach. Learn."},{"key":"ref_31","first-page":"775","article-title":"New Oral Anti-Cancer Drugs and Medication Safety","volume":"116","author":"Schlichtig","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005110-200003000-00003","article-title":"A Comparison of Time-and-Motion and Self-Reporting Methods of Work Measurement","volume":"30","author":"Burke","year":"2000","journal-title":"J. Nurs. Adm."},{"key":"ref_33","first-page":"e57176","article-title":"Enhancing Hospital Pharmacy Operations Through Lean and Six Sigma Strategies: A Systematic Review","volume":"16","author":"Sallam","year":"2024","journal-title":"Cureus"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/9\/523\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:51:11Z","timestamp":1788857471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/9\/523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["curroncol33090523"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33090523","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}